Emergent Biosolutions, Inc. Share Price
NYSE: EBSHealthcare
Live Emergent Biosolutions, Inc. Share Price Chart
O H L
Emergent Biosolutions, Inc. Performance Overview
Days Range
▼
$6.93Low
$7.02High
Markets Today
| Previous Close | $7.02 |
|---|---|
| Open | $6.97 |
| Volume | 198,529 |
| Day's Range | $6.93 - $7.02 |
| 52W Range | $4.36 - $14.06 |
| Market Cap | $346.10 M |
Historical Performance
| 1M Returns | +50.64 |
|---|---|
| 3M Returns | -12.25 |
| 6M Returns | -12.25 |
| 1Y Returns | -11.59 |
| 5Y Returns | -87.71 |
| 10Y Returns | -73.99 |
Emergent Biosolutions, Inc. Fundamentals
| Market Cap | $346.10 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $742.90 M |
| ROE TTM | 0.10 |
| EPS TTM | $-3.51 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.01 |
| EBITDA | $208.10 M |
| Profit Margin | 7.08 |
| Market Cap | $346.10 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $742.90 M |
| ROE TTM | 0.10 |
| EPS TTM | $-3.51 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.01 |
| EBITDA | $208.10 M |
| Profit Margin | 7.08 |
Emergent Biosolutions, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $222.20 M | $140.90 M | $231.10 M | $148.70 M | $156.10 M | $234.30 M |
| Gross Profit + | $133.70 M | $74.00 M | $145.20 M | $63.80 M | $84.10 M | $137.20 M |
| Operating Income | $49.90 M | $1.60 M | $76.50 M | -$27.90 M | $10.50 M | -$125.10 M |
| EBITDA | $75.30 M | $25.10 M | $99.90 M | $7.80 M | $34.00 M | $90.20 M |
| Interest Expense | -$14.70 M | -$14.70 M | -$15.20 M | -$14.70 M | -$11.00 M | -$10.00 M |
| Depreciation | $25.40 M | $23.50 M | $23.40 M | $35.70 M | $23.50 M | $215.30 M |
| Income Before Tax | $92.70 M | -$16.80 M | $57.60 M | -$50.70 M | $13.40 M | -$166.30 M |
| Income Tax Expense | $24.70 M | -$4.80 M | $6.40 M | $3.90 M | $6.60 M | $13.90 M |
| Net Income + | $68.00 M | -$12.00 M | $51.20 M | -$54.60 M | $6.80 M | -$180.20 M |
| Net Profit Margin | 30.6% | -8.52% | 22.15% | -36.72% | 4.36% | -76.91% |
Emergent Biosolutions, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $100.00 K | $100.00 K | $100.00 K | $100.00 K | $100.00 K | $100.00 K |
| Reserve & Surplus | -$150.50 M | -$164.50 M | -$112.70 M | -$167.30 M | -$159.90 M | -$340.00 M |
| Non-Current Liabilities | $761.50 M | $753.80 M | $742.00 M | $663.80 M | $648.60 M | $652.60 M |
| Current Liabilities | $107.10 M | $122.40 M | $132.00 M | $132.20 M | $148.70 M | $122.80 M |
| Total Liabilities | $873.40 M | $880.90 M | $878.50 M | $796.00 M | $797.30 M | $775.40 M |
| Fixed Assets | $706.20 M | $685.10 M | $662.50 M | $641.90 M | $669.80 M | $439.80 M |
| Current Assets | $706.80 M | $719.50 M | $786.90 M | $662.50 M | $637.60 M | $666.00 M |
| Total Assets | $1.43 B | $1.42 B | $1.46 B | $1.32 B | $1.32 B | $1.12 B |
Emergent Biosolutions, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $68.00 M | -$12.00 M | $51.20 M | -$54.60 M | $6.80 M | -$180.20 M |
| Operating Cash Flow | -$11.20 M | $106.40 M | -$2.30 M | $77.70 M | -$33.80 M | $56.10 M |
| Investing Cash Flow | $59.50 M | $17.20 M | -$3.40 M | -$3.90 M | -$2.40 M | -$52.30 M |
| Financing Cash Flow | -$400.00 K | -$6.40 M | -$15.90 M | -$113.90 M | -$11.40 M | -$24.40 M |
| Change in Cash | $47.20 M | $118.20 M | -$21.80 M | -$40.10 M | -$47.60 M | -$20.60 M |
Emergent Biosolutions, Inc. Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $644.12B | 64.02% | 30.99 | 28.46% | 2.01% |
Emergent Biosolutions, Inc. Return Calculator
The Emergent Biosolutions, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,223
Invested Amount$10,000
Est. Returns$-8,777
About Emergent Biosolutions, Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Popular Stocks
FAQs
What is the share price of Emergent Biosolutions, Inc. today?
Emergent Biosolutions, Inc. (EBS) share price as of September 18, 2026 is $6.99. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Emergent Biosolutions, Inc.?
Yes, Indian Investors can invest in the Emergent Biosolutions, Inc. (EBS) Share by opening an international trading account with Angel One.
How can I purchase Emergent Biosolutions, Inc. shares in India?
Purchasing Emergent Biosolutions, Inc. (EBS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Emergent Biosolutions, Inc. (EBS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Emergent Biosolutions, Inc.?
Yes, you can purchase fractional shares of Emergent Biosolutions, Inc. (EBS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Emergent Biosolutions, Inc.?
The market capitalization of Emergent Biosolutions, Inc. on September 18, 2026, is $346.10 M.
In which sector Emergent Biosolutions, Inc. belongs?
Emergent Biosolutions, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Emergent Biosolutions, Inc. stocks?
In order to invest in Emergent Biosolutions, Inc. (EBS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
